Pemetrexed Disodium in Treating Patients With Recurrent Cancer of the Cervix

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

August 31, 2004

Primary Completion Date

June 30, 2006

Conditions
Cervical Cancer
Interventions
DRUG

pemetrexed disodium

Trial Locations (22)

11203

SUNY Downstate Medical Center, Brooklyn

13210

SUNY Upstate Medical University Hospital, Syracuse

18105

Morgan Cancer Center at Lehigh Valley Hospital - Cedar Crest, Allentown

19001

Rosenfeld Cancer Center at Abington Memorial Hospital, Abington

28801

Hope A Women's Cancer Center, Asheville

44106

Case Comprehensive Cancer Center, Cleveland

44109

MetroHealth's Cancer Care Center at MetroHealth Medical Center, Cleveland

44124

Hillcrest Cancer Center at Hillcrest Hospital, Mayfield Heights

60521

Hinsdale Hematology Oncology Associates, Hinsdale

64131

CCOP - Kansas City, Kansas City

65804

St. John's Regional Health Center, Springfield

72205

Arkansas Cancer Research Center at University of Arkansas for Medical Sciences, Little Rock

73104

Oklahoma University Medical Center, Oklahoma City

74104

Cancer Care Associates - Midtown Tulsa, Tulsa

75390

Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas, Dallas

89102

Women's Cancer Center - Las Vegas, Las Vegas

97301

Williamette Gynecologic Oncology P.C., Salem

95350-4138

Doctors Medical Center, Modesto

06105

Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center, Hartford

27599-7295

Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill

77030-4009

M.D. Anderson Cancer Center at University of Texas, Houston

23298-0037

Massey Cancer Center at Virginia Commonwealth University, Richmond

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Gynecologic Oncology Group

NETWORK

NCT00087113 - Pemetrexed Disodium in Treating Patients With Recurrent Cancer of the Cervix | Biotech Hunter | Biotech Hunter